LinkedIn Profile

Access scPharmaceuticals historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:scph 3796952 Apr 14th, 2024 12:00AM scPharmaceuticals 4.1K 125.00 Open Apr 13th, 2024 11:40PM Apr 13th, 2024 11:40PM scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (IV) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs. Open Improving Diuresis in Heart Failure, Next Generation OPAT, Medical Countermeasure Solutions, and Heart Failure Open 25 Mall Road, Suite 203 Burlington MA US 01803 scPharmaceuticals
nasdaq:scph 3796952 Apr 13th, 2024 12:00AM scPharmaceuticals 4.1K 125.00 Open Apr 12th, 2024 11:32PM Apr 13th, 2024 12:05PM scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (IV) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs. Open Improving Diuresis in Heart Failure, Next Generation OPAT, Medical Countermeasure Solutions, and Heart Failure Open 25 Mall Road, Suite 203 Burlington MA US 01803 scPharmaceuticals
nasdaq:scph 3796952 Apr 12th, 2024 12:00AM scPharmaceuticals 4.1K 125.00 Open Apr 11th, 2024 11:38PM Apr 12th, 2024 09:01AM scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (IV) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs. Open Improving Diuresis in Heart Failure, Next Generation OPAT, Medical Countermeasure Solutions, and Heart Failure Open 25 Mall Road, Suite 203 Burlington MA US 01803 scPharmaceuticals
nasdaq:scph 3796952 Apr 11th, 2024 12:00AM scPharmaceuticals 4.1K 125.00 Open Apr 11th, 2024 12:15AM Apr 11th, 2024 11:46AM scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (IV) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs. Open Improving Diuresis in Heart Failure, Next Generation OPAT, Medical Countermeasure Solutions, and Heart Failure Open 25 Mall Road, Suite 203 Burlington MA US 01803 scPharmaceuticals
nasdaq:scph 3796952 Apr 10th, 2024 12:00AM scPharmaceuticals 4.1K 125.00 Open Apr 9th, 2024 11:40PM Apr 10th, 2024 05:53PM scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (IV) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs. Open Improving Diuresis in Heart Failure, Next Generation OPAT, Medical Countermeasure Solutions, and Heart Failure Open 25 Mall Road, Suite 203 Burlington MA US 01803 scPharmaceuticals
nasdaq:scph 3796952 Apr 9th, 2024 12:00AM scPharmaceuticals 4.1K 125.00 Open Apr 8th, 2024 11:50PM Apr 9th, 2024 10:35AM scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (IV) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs. Open Improving Diuresis in Heart Failure, Next Generation OPAT, Medical Countermeasure Solutions, and Heart Failure Open 25 Mall Road, Suite 203 Burlington MA US 01803 scPharmaceuticals
nasdaq:scph 3796952 Apr 8th, 2024 12:00AM scPharmaceuticals 4.1K 125.00 Open Apr 8th, 2024 12:22AM Apr 8th, 2024 07:32PM scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (IV) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs. Open Improving Diuresis in Heart Failure, Next Generation OPAT, Medical Countermeasure Solutions, and Heart Failure Open 25 Mall Road, Suite 203 Burlington MA US 01803 scPharmaceuticals
nasdaq:scph 3796952 Apr 7th, 2024 12:00AM scPharmaceuticals 4.1K 125.00 Open Apr 6th, 2024 11:45PM Apr 6th, 2024 11:45PM scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (IV) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs. Open Improving Diuresis in Heart Failure, Next Generation OPAT, Medical Countermeasure Solutions, and Heart Failure Open 25 Mall Road, Suite 203 Burlington MA US 01803 scPharmaceuticals
nasdaq:scph 3796952 Apr 6th, 2024 12:00AM scPharmaceuticals 4.1K 125.00 Open Apr 5th, 2024 11:45PM Apr 5th, 2024 11:45PM scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (IV) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs. Open Improving Diuresis in Heart Failure, Next Generation OPAT, Medical Countermeasure Solutions, and Heart Failure Open 25 Mall Road, Suite 203 Burlington MA US 01803 scPharmaceuticals
nasdaq:scph 3796952 Apr 5th, 2024 12:00AM scPharmaceuticals 4.1K 125.00 Open Apr 5th, 2024 12:28AM Apr 5th, 2024 12:28AM scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (IV) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs. Open Improving Diuresis in Heart Failure, Next Generation OPAT, Medical Countermeasure Solutions, and Heart Failure Open 25 Mall Road, Suite 203 Burlington MA US 01803 scPharmaceuticals

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.